{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:38:02Z","timestamp":1773283082153,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University Research Council Grant","award":["10GS022P&M"],"award-info":[{"award-number":["10GS022P&M"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.anaerobe.2015.03.006","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T07:17:10Z","timestamp":1427267830000},"page":"132-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["High rate of non-susceptibility to metronidazole and clindamycin in\u00a0anaerobic isolates: Data from a clinical laboratory from Karachi, Pakistan"],"prefix":"10.1016","volume":"33","author":[{"given":"Sadia Omer","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kauser","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Qaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Tanwir","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afia","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2015.03.006_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anaerobe.2005.10.004","article-title":"Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing","volume":"12","author":"Hecht","year":"2006","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2015.03.006_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/512197","article-title":"Reemergence of anaerobic bacteremia","volume":"44","author":"Lassmann","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/421558","article-title":"Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments","volume":"39","author":"Hecht","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anaerobe.2011.12.022","article-title":"Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF","volume":"18","author":"Trevi\u00f1o","year":"2012","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2015.03.006_bib5","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/AAC.00355-08","article-title":"Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems","volume":"52","author":"Liu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinmicnews.2010.12.001","article-title":"Resistance trend in antimicrobial susceptibility of anaerobic bacteria, Part 1","volume":"33","author":"Goldstein","year":"2011","journal-title":"Clin. Microbiol. News Lett."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib7","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1128\/AAC.00081-08","article-title":"Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain","volume":"52","author":"Betriu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib8","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1128\/AAC.00481-10","article-title":"Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea","volume":"54","author":"Y1","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/cid\/cir664","article-title":"Clinical efficacy and correlation of clinical outcomes with in\u00a0vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin","volume":"53","author":"Goldstein","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciu395","article-title":"Antimicrobial resistance and susceptibility testing of anaerobic bacteria","author":"Schuetz","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib11","unstructured":"Clinical Laboratory Institute Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard, eighth ed. (M11\u2013A8)."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0277-9536(95)00386-X","article-title":"Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan","volume":"42","author":"Nizami","year":"1996","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib13","first-page":"50","article-title":"Lessons learned from the anaerobe survey: historical perspective and review of the most recent data","volume":"2010","author":"Syndman","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib14","first-page":"584","volume":"vol. 22","author":"Sultan","year":"2013"},{"key":"10.1016\/j.anaerobe.2015.03.006_bib15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/AAC.05622-11","article-title":"First National survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina","volume":"56","author":"Fernandes-Canigia","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib16","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkq321","article-title":"German multicentre survey of the antibiotic susceptibility of Bacteroides fragilis group and Prevotella species isolated from intra-abdominal infections: results from the PRISMA study","volume":"65","author":"Seifert","year":"2010","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.anaerobe.2015.03.006_bib17","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/503907","article-title":"Fluoroquinolone and anaerobes","volume":"42","author":"Stein","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.anaerobe.2015.03.006_bib18","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/378809","article-title":"Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones","volume":"37","author":"Saravolatz","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib19","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/AAC.43.6.1475","article-title":"Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections","volume":"43","author":"Goldstein","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0924-8579(03)00087-6","article-title":"Activity of linezolid against anaerobic bacteria","volume":"22","author":"Behra-Miellet","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.anaerobe.2015.03.006_bib21","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1086\/428623","article-title":"Anaerobic sepsis due to multidrug-resistant bacteroides fragilis: microbiological cure and clinical response with linezolid therapy","volume":"40","author":"Wareham","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1099\/jmm.0.049825-0","article-title":"Multidrug-resistant Bacteroides fragilis group on the rise in Europe?","volume":"61","author":"Hartmeyer","year":"2012","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.anaerobe.2015.03.006_bib23","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1086\/516355","article-title":"Clinical significance and outcome of anaerobic bacteremia","volume":"26","author":"Salonen","year":"1998","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.anaerobe.2015.03.006_bib24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/313805","article-title":"Antimicrobial resistance and clinical outcome of bacteroides bacteremia: findings of a multicenter prospective observational trial","volume":"30","author":"Nguyen","year":"2000","journal-title":"Clin. Infect. Dis."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996415000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996415000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T11:00:35Z","timestamp":1566471635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996415000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":24,"alternative-id":["S1075996415000451"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2015.03.006","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High rate of non-susceptibility to metronidazole and clindamycin in\u00a0anaerobic isolates: Data from a clinical laboratory from Karachi, Pakistan","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2015.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}